GW Henssler & Associates Ltd. Has $649,000 Stock Position in Procter & Gamble Company (The) $PG

GW Henssler & Associates Ltd. boosted its holdings in shares of Procter & Gamble Company (The) (NYSE:PG) by 2.3% during the 2nd quarter, Holdings Channel reports. The institutional investor owned 4,074 shares of the company’s stock after buying an additional 92 shares during the period. GW Henssler & Associates Ltd.’s holdings in Procter & Gamble were worth $649,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Nova Wealth Management Inc. acquired a new position in Procter & Gamble during the first quarter valued at $26,000. Signature Resources Capital Management LLC boosted its position in Procter & Gamble by 67.9% during the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock valued at $28,000 after purchasing an additional 72 shares during the last quarter. Quarry LP acquired a new stake in Procter & Gamble during the first quarter valued at $33,000. Mizuho Securities Co. Ltd. boosted its position in Procter & Gamble by 566.7% during the first quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company’s stock valued at $34,000 after purchasing an additional 170 shares during the last quarter. Finally, RMG Wealth Management LLC acquired a new stake in Procter & Gamble during the second quarter valued at $37,000. 65.77% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Procter & Gamble

In related news, CEO Jon R. Moeller sold 40,119 shares of the business’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $6,309,515.13. Following the completion of the transaction, the chief executive officer owned 319,375 shares of the company’s stock, valued at approximately $50,228,106.25. The trade was a 11.16% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, COO Shailesh Jejurikar sold 13,039 shares of the business’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $2,050,643.53. Following the transaction, the chief operating officer directly owned 28,036 shares of the company’s stock, valued at $4,409,221.72. This represents a 31.74% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 149,763 shares of company stock worth $23,421,279 in the last ninety days. 0.20% of the stock is owned by insiders.

Procter & Gamble Stock Down 0.6%

PG stock opened at $149.69 on Monday. The stock has a market capitalization of $350.34 billion, a price-to-earnings ratio of 22.99, a price-to-earnings-growth ratio of 3.97 and a beta of 0.36. The company has a 50-day moving average of $155.24 and a two-hundred day moving average of $159.41. Procter & Gamble Company has a 52-week low of $149.45 and a 52-week high of $180.43. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The business had revenue of $20.89 billion during the quarter, compared to analysts’ expectations of $20.79 billion. During the same quarter in the previous year, the firm earned $1.40 EPS. The firm’s revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities research analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.

Analyst Ratings Changes

A number of analysts recently issued reports on PG shares. Barclays reduced their price objective on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 1st. BNP Paribas Exane reduced their price objective on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research report on Tuesday, September 23rd. Evercore ISI reissued an “in-line” rating and set a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. JPMorgan Chase & Co. reduced their price objective on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating for the company in a research report on Friday. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Procter & Gamble in a research report on Wednesday, October 8th. Eleven analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $172.21.

Procter & Gamble Company Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.